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Abstract Patientswith bronchiectasis often complain of abnormal tiredness, difficulty in concentrating or low spirits.
This studywascarriedoutto examinelevels of anxietyanddepressioninbronchiectasis andtheirrelationshipwithother
measures of lunghealth.Onehundred and elevenpatientswith bronchiectasis determinedbyhigh-resolution computed
tomography (CT) scanwere studied using a range of physiological and psychological outcomemeasures.Patients com-
pleted anxietyand depression, health status (qualityof life), fatigue and dypnoea questionnaires.Lung functionwasmea-
sured and exercise capacity was assessed using a shuttlewalk test. Anxiety and depression scores formed a continuum.
Moderate–severe anxiety was more frequent than equivalent levels of depression (17 vs 9% of patients). Anxiety and
depression scores were associated with perceived health status (r=0.33 and 0.55).Neither anxiety nor depressionwas
associated with the extent of bronchiectasis on CTscan.Depression was correlated with breathlessness and exercise
performance (r=0.33 and 0.40), but anxiety was not.The correlation between depression and exercise performance
was not simply due to the influence of somatic items in the depression questionnaire.We conclude that anxiety and de-
pression are quite common in bronchiectasis in that 34% of patients had elevated scores for anxiety, depression or both.
The non-somatic components of depressionwere linked to dyspnoea and exercise performance, but anxiety was only
related to perceived health.Therefore, treatment aimed at reducing symptoms and improving exercise capacity will not
reduce levels of anxietywhichneed alternative therapy.r2002 Elsevier Science Ltd.Allrights reserved.
doi:10.1053/rmed.2002.1330, available online athttp://www.idealibrary.comon
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Bronchiectasis is a chronic lung condition in which da-
mage to the large airways leads to abnormal dilation of
one or more bronchi and results in poor clearance and
pooling of mucus in the a¡ected areas. Commonly re-
ported symptoms include daily cough and sputum pro-
duction, wheeze, breathlessness and fatigue. This can
lead to reduced exercise capacity and a reduced ability
to carry out activities of daily living. Bronchiectasis dif-
fers from other common airways diseases such as
chronic obstructive pulmonary disease and asthma, in
that su¡erers produce a greater volume of sputum and
experience recurrent or chronic infections much more
frequently (1,2).
One e¡ect of chronic disease may be mood impair-
ment that persists despitemaximummedical treatment.Received1October 2001, accepted in revised form 6March 2002
Correspondence should be addressed to:Dr RobertWilson,Host
Defence Unit, Royal Brompton Hospital, Sydney Street, London SW3
6NP,U.K.Fax: +207 3518338; E-mail: r.wilson@rbh.nthames.nhs.ukThis raises the possibility of using mood-altering
drugs to provide symptomatic bene¢t in patients with
chronic physical disease. This approach causes concern,
however, since symptoms are an important marker
of disease activity. These might be masked by the
use of drugs that make patients feel better without
having any e¡ect on the underlying disease process in
the lungs. A further concern is that anxiety and depres-
sion occur within individuals who have no organic dis-
ease, so if mood state impairment is present, the
question arises as towhether this is a co-existent distur-
bance or the result of the organic disease and its conse-
quences.
This study was carried out to examine mood impair-
ment inbronchiectasis although it iswell recognised that
patients with bronchiectasis often complain of abnormal
tiredness, di⁄culty in concentrating or low spirits (1,2), a
formal study of patients mood and its relation to other
measures of lunghealth has notbeenundertaken before.
Two principle hypotheseswereunder test: (1) thatmood
state and disease severity are related; (2) that there is a
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pairment that this is out of proportion to any lung
disease-related e¡ect. We also wished to investigate
the possibility that there may be cross-contamination
betweenmeasures of depression, which is characterised
by psycho-motor retardation, and those that measure
disturbance of physical activity secondary to organic
causes. To minimise this e¡ect, we used a mood state
questionnaire that was developed speci¢cally for use in
patients with organic disease: the Hospital Anxiety and
Depression Scale (3).The depression component of this
instrument contains only one item of a somatic nature.
We hypothesised that if there were a relationship be-
tween depression and disease severity, this may be in£u-
enced by the somatic item in the questionnaire. The
present study was carried out at the same time as a
study to validate the St George’s respiratory question-
naire in bronchiectasis (4).
METHODS
Patients were recruited from the Host Defence Unit
outpatients clinics at the Royal Brompton Hospital over
a 4 month period. Patients attending the clinic who had
been diagnosed with bronchiectasis, both clinically and
by high-resolution computed tomography (HRCT), were
approached to take part in the study. In every case, the
major clinical presentationwas causedbybronchiectasis.
In total, 120 patients were approached.Of these, 111 pa-
tients (44 males) agreed to take part andwere recruited
into the study. All patients were British or had lived in
the UK for many years. Details of the aetiology were
recorded from their medical records.The study was ap-
proved by the Royal Brompton Hospital Ethics Commit-
tee.Written consentwas obtained.
The patients completed the Hospital Anxiety andDe-
pression Scale (HADS), the St George’s Respiratory
Questionnaire (SGRQ), a fatigue questionnaire and the
Medical Research Council (MRC) dyspnoea scale in a
randomised order. Further details of each of these mea-
sures are provided below. Patients also completed tests
of lung function and shuttle walk test. A HRCTscan for
each patient was obtained. The scan acquisition para-
meters were 1.5mm sections at 10mm intervals with
the patient supine and breath-holding at near total lung
capacity. Images were photographed at ^500 H.U. (cen-
tre) and1000 H.U. (width).
Questionnaires
Hospital Anxiety and Depression Scale (HADS); The HADS
was developed tomeasure anxiety and depression speci-
¢cally in patients with chronic disease (3).For both anxi-
ety and depression scales, there are seven questions,
each of which are scored on a scale of 0^3. The scoresfor both the Anxiety and Depression scale can be inter-
preted in the following way: 0^7 = normal, 8^10 = mild,
11^21 = moderate-severe (5).Measurement of psycholo-
gical disturbance in any chronic disease may be compli-
cated if physical markers that are assumed to be
associated with the patient’s psychological state also oc-
cur as a direct result of the underlying disease. The
HADS has been found to be free of this ‘criterion con-
tamination’ when used in patients with rheumatoid ar-
thritis (6). When used in the context of chronic lung
disease, the HADS contains one somatic item thatmight
relate to physical impairment as a result of the condition.
This was Depression Item 4 (I feel as if I am slowed
down).To investigate the impact of this item, the depres-
sion component of the HADS was calculated in two
ways: using all seven items that normally make up this
scale including item Depression Item 4 (Depression) and
without Depression Item 4 (Depression-D4).
St George’s Respiratory Questionnaire (SGRQ):The SGRQ
was developed tomeasurehealth status (qualityof life) in
patientswith respiratorydisease (7). It has recentlybeen
shown to be reliable, valid and responsive when used in
patientswithbronchiectasis (4).Component scoresmea-
suring symptoms (Symptoms), impacts on daily life (Im-
pacts), disturbance to daily activities (Activity) and an
overall (Total) score are produced. Each component and
theTotal is scored on a scale of zero to 100, with zero
being the best possible score and100 being theworst.
Fatigue questionnaire:This14-item scalewas developed
to measure severity of fatigue (8). A Physical Fatigue
score, a Mental Fatigue score and an Overall score are
produced. The questionnaire has demonstrated validity
and reliability in a general population. It has been recom-
mended for use in both hospital and community popula-
tions.
MRC Dyspnoea scale: The Medical Research Council
(MRC) Dyspnoea scale is a standardised scale used to
measure breathlessness (9). Patients grade themselves
on a 5-point scale fromGrade1 (breathless with strenu-
ous exercise) to Grade 5 (too breathless to leave the
house or breathless when dressing).
Shuttle walk test and lung function:The shuttlewalk test
is a standardised incremental paced walking test which
measures symptom-limited maximal performance by
requiring individuals to walk around two stationary
conesplaced10m apart at an increasing speed (10). Com-
prehensive lung function tests includingmeasurement of
anterial blood gases by earlobe sampling weremade.
High-resolution computed tomography
(HRCT)
AHRCTscanwas obtainedin eachpatient, then assessed
and scored by the same pulmonary radiologist (DMH)
who was blinded to all other details concerning the pa-
FIG. 1. Frequency distribution of anxiety scores obtainedwith
the Hospital Anxiety and Depression Scale in patients with
bronchiectasis. A higher score indicates more anxiety. A score
of eight is the threshold forclinically signi¢cant anxiety.
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changes on a 0^3 scale, where 0 = no bronchiectasis; 1
= one or less than one bronchopulmonary segment in-
volved; 2 = more than one bronchopulmonary segment
involved; 3 = gross cystic bronchiectasis. This scoring
system has been used in previous studies and is asso-
ciated with low inter-observer variation (11,12).To adjust
the scores of those patients who had lobectomies, the
bronchiectasis score was calculated as a percentage of
themaximumpoints available.
Analysis
Parametric anddistribution-independent testswereper-
formed throughout the analyses.Nomajor discrepancies
between these two approacheswere found, however, so
the results are presented using results from the para-
metric tests to allow easier assessment of the size of
the association between variables. Signi¢cance was ac-
cepted at a 5% probability level.
RESULTS
Patient details
Data from 111 (44 male) patients were used in this
study.Theirmean agewas 52 years (SD13).The aetiologies
included: 64 with idiopathic bronchiectasis,11with aller-
gic bronchopulmonary aspergillosis,10withhypogamma-
globulinaemia , 10 with post-infective bronchiectasis, 10
with primary ciliary dyskinesia orYoung’s syndrome and
six in whom bronchiectasis was associated with in£am-
matory bowel disease. Data from the idiopathic
groupwere analysed separately to seewhether the pre-
sence of co-morbid illness a¡ected the results. As no
discrepancies were found when other aetiologies
were excluded, results from the complete sample are
presented. Mean HRCT bronchiectasis score was 40.9%
(SD19.6).
Mean FEV1, expressed as a percentage of the pre-
dicted value (% pred), was 66.4% pred (SD 28.8). Mean
oxygen (PaO2) was 10.2 kPa (SD 5.9). Mean Dyspnoea
scorewas 2.1 (SD1.0).Mean shuttle exercise distancewas
473m (SD 258).The mean Physical Fatigue score was 4.7
(SD 2.5),Mental Fatiguewas 2.2 (SD1.9) and theTotal Fati-
gue scorewas 6.0 (SD 3.8).Themean SGRQ scores were:
Symptoms 71 (SD 20), Activity 49 (SD 25), Impacts 34 (SD
19), total 44 (SD18).
Anxiety and Depression
The mean Anxiety score was 6.3 (SD 4.5).The frequency
distribution for this score is shown in Fig. 1. Although it
was slightly skewed with an extended tail towards the
higher scores, therewas no evidence of a bimodal distri-
bution.ThemeanDepression scorewas 4.5 (SD 3.4), againthe distributionwas skewed but there is no evidence for
thepresence of two di¡erent sub-populatoins of patients
(Fig. 2 upper panel). Scatter graphs for Anxiety and De-
pression scores were also examined.These did not show
any cut-o¡ point to mark a bimodal distribution for
either anxiety or depression.
The Anxiety score correlated quite strongly with
Depression (r=0.67, Po0.001). Patients were categorised
as ‘normal’, ‘mild’, ‘moderate’ and ‘severe’ anxiety and de-
pression according to the scoring bands described
in the methods section.Using the Anxiety scale: 69% of
patients scored ‘normal’, 14% ‘mild’, 17% ‘moderate ^se-
vere’. On the Depression scale: 85% of patients scored
‘normal’, 5% ‘mild’, 9% ‘moderate ^ severe’. In all, 34% of
patients had elevated scores for Anxiety, Depression or
both.
The distribution of the responses to the somatic De-
pression item (itemD4) is also shown in Fig. 2 (lower pa-
nel). These are distributed along the x-axis at intervals
corresponding to the comparable points for the whole
7-itemDepression scale (note: a response of ‘one’ to each
of the seven items produces a score of ‘seven’ for the
whole scale).Responses to the single somatic component
of the Depression scale were distributed towards the
higher end of the scaling range compared to the scores
for the whole 7-item Depression scale. The association
between the full 7-item Depression score and the score
from the six items excluding the somatic item (Depres-
sion-D4) was only moderate (r=0.51; Po0.0001, i.e. 26%
shared variance).
Association of anxiety anddepressionwith
gender, age anddisease aetiology
Unpaired t-testswereused to test for di¡erences in anxi-
ety and depression between male and female patients.
FIG. 2. Upper panel: Frequency distribution of Depression
scoresobtainedwiththeHospital AnxietyandDepression Scale
in patients with bronchiectasis. A higher score indicates more
depression. A score of eight is the threshold for clinically signi¢-
cant depression. Lower panel: Frequency distribution of the re-
sponses to the single somatic item (‘‘I feel as if I am slowed
down’’) containedintheHospital AnxietyandDepression Scale.
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sion, Depression-D4 or item D4 between male and fe-
male patients (t= 1.5,1.7,1.8 and0.6, respectively;
all P40.05). Pearson’s r, calculated to examine the rela-
tionship between age and Anxiety, Depression, Depres-
sion-D4 or item D4 was not signi¢cant (r= 0.02, 0.18,
0.17, and 0.14, respectively; all P40.05). ANOVAs calcu-
lated to examine the relationship between diseaseTABLE 1. Correlationbetweenthe HADS and the SGRQ
SGRQ
Symptoms
HADSAnxiety 0.20*
HADSDepression 0.34***
HADSDepression-D4 0.27**
ItemD4 0.43***
De¢nition of abbreviations: SGRQ = St George’s Respirator
Scale.Correlations are Pearson rcoe⁄cient.
*Po0.05; **Po0.01; ***Po0.001aetiology and Anxiety, Depression, Depression-D4 or
item D4 were not signi¢cant (F=0.41, 0.67, 0.69 and 0.70;
all P40.05).
Association of anxiety anddepressionwith
health status
Pearson’s correlation coe⁄cientwas calculatedbetween
the HADS scores and the SGRQ.Correlations between
Anxiety and the component scores of the SGRQ were
weaker than those between Depression and SGRQ
score (Table 1). Item D4 correlated more strongly with
each SGRQ component than did the overall Depression
score. Correspondingly, Depression-D4 correlated with
the SGRQ scores more weakly than did the full 7-item
Depression score.Neither Anxiety nor any index ofDe-
pression correlated with HRCT bronchiectasis score
(Table 2).
Association of anxiety anddepressionwith
physiological function
All three measures of depression correlated with exer-
cise performance, with D4 being the strongest correlate
(Table 2). The relationship between overall Depression
and exercise performance is illustrated in Fig. 3. Since
the causality in this relationship could be in either direc-
tions both x vs y and y vs x plots are presented. Three
features are of note. First, the scatter was normally dis-
tributed around the regression. Second, there was no
evidence of non-linearity. Third, with the exception of
one patient with a high Depression score, none of the
other patients appeared to depart from the overall De-
pression^ exercise relationship.None of themood state
scores correlatedwith FEV1or PaO2.
Association of anxiety anddepressionwith
fatigue anddyspnoea
Anxiety and Depression correlated with Physical Fati-
gue,Mental Fatigue andOverall Fatigue (Po0.001in eachSGRQ SGRQ SGRQ
Activity Impacts Total
0.23* 0.38*** 0.33***
0.44*** 0.58*** 0.55***
0.37*** 0.50*** 0.41***
0.50*** 0.60*** 0.60***
y Questionnaire, HADS = Hospital Anxiety and Depression
TABLE 2. Correlationsbetweenthe HADS and fatigue, dyspnoea,ShuttleWalk test and FEV1 (% pred)
HRCT Shuttle FEV1 PaO2 Physical Mental Total Dyspnoea
score walk test (% pred) fatigue fatigue fatigue
HADS anxiety 0.05ns 0.02ns 0.06ns 0.08ns 0.36* 0.56* 0.51* 0.16ns
HADS 0.05ns 0.33* 0.02ns 0.10ns 0.55* 0.54* 0.62* 0.40*
Depression
HADS 0.02ns 0.29* 0.02ns 0.09ns 0.47* 0.52* 0.57* 0.35*
Depression-D4
ItemD4 0.13ns 0.39* 0.13ns 0.10ns 0.60* 0.45* 0.61* 0.51*
De¢nition of abbreviations:FEV1 = forced expiratory volume in1s,HADS =Hospital Anxiety and Depression scale
Correlations are Pearson rcoe⁄cient
ns P4 0.05; * Po 0.001
Note:Only 96 ofthe111patients had PaO2 measuredbyearlobe oximetry.
FIG. 3. Plots ofthe relationship between depression and exer-
cise limitation presented as x vs y and y vs x plots.The outlying
patient with a veryhigh depression score is shownwith a closed
symbol. The Pearson r value for the correlation was 0.33, P=
0.0004.
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of correlation between the di¡erent measures of mood
state and the components of fatigue, although Anxiety
appeared to correlate a little less strongly with Physical
Fatigue (13% shared variance compared to 20^37% for allthe other comparisons). Anxiety did not correlate with
dyspnoea (shared variance 3%, Table 1). In contrast,
dyspnoea was correlated with all Depression scores
(Po0.001), the weakest correlate was that with Depres-
sion-D4 where the share variancewas12%.
DISCUSSION
In this study, one-third of patients had evidence of clini-
cally signi¢cant mood impairment.The scores appeared
to form a continuum, with no evidence of any discrete
sub-populations of clinically anxious or depressed pa-
tients. Anxiety and depressionwere both related to fati-
gue and impairment of health status, the latter being
measured using a validated disease-speci¢c question-
naire for chronic lung disease. Thus, patients with ele-
vated anxiety and depression feel more tired and will
report greater impairment of their daily life and well-
being than patients without signi¢cant mood impair-
ment.
Neither anxiety nor any index of depression corre-
lated with the extent of bronchiectasis on CT scan.
Therefore, this study did not show a relationship be-
tween mood state and disease severity. In a previous
study, we found a similar lack of correlation between ex-
tent of bronchiectasis and health status (13). However,
we have also shown that many features of the disease
such as the level of in£ammation in the lung, the type of
bacterial infection, exercise capacity and the frequency
of exacerbations do in£uence health status, but they are
dependent on other factors in addition to structural ab-
normality (4,13,14). Future studies should investigate how
these other features of bronchiectasis in£uence mood
state.
The study raises some important issues concerning
the nature of the relationship between lung disease and
mood state. Whilst the Anxiety score was associated
with the patients’ perception of their health and well-
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marker of disease activity. In contrast, depression was
associatedwith thepatients’ level of exercise impairment
in the laboratory and their level of breathlessness in daily
life.This association appears to havebeendue inpart to a
linkage between the somatic manifestations of depres-
sion and physical limitation due to organic disease. Re-
stricting the depression questionnaire to those items
that did not have somatic features reduced the strength
of the association with exercise performance and dys-
pnoea in daily life, but did not abolish it. We conclude
that the link between depression and exercise tolerance
is not simply due to cross-contamination in themethods
of assessment.
Bronchiectasis patients may complain of tiredness in
themiddle of the day, di⁄culty in concentrating and low
spirits (1,2). In this study, patients with reduced exercise
capacity and a high level of breathlessness experienced a
poor level of health status anddepression.Thosewho ex-
perienced high levels of both physical andmental fatigue
were also likely to experience reduced health status and
depression.This suggests that these symptoms were re-
lated to bronchiectasis-related disease activity, although
a true endogenous component in those patients with
clinically signi¢cant depression cannot be ruled out on
the basis of this study. A longitudinal designed study
would be required to answer this question. Physiother-
apy forms the basis of bronchiectasis management, but
is poorly adhered to bypatients (1,2).Thepatientsmental
state may in£uence how often they carry out postural
drainage. Treatment aimed at improving bronchiectasis
symptoms, which are largely thought to be due to neu-
trophilic in£ammation in the airways caused by bacterial
infections (1,2) is likely to improve health status and de-
pression, although any change in health status or depres-
sion should bemeasured directly rather than inferred.
In these patients, anxiety appeared to be a more spe-
ci¢c variable than depression since the latter was related
to both objective and subjective measures of impaired
health, including exercise tolerance. In contrast, anxiety
only related to perceived health. In anxious individuals,
theremaybe amismatch between perception and actual
ability, with patients perceiving themselves to be less
able than they actually are, and needlessly avoiding var-
ious situations. This phenomenon was observed byYel-
lowlees and Kalucy (15) in an asthmatic population.
Anxiety was not related to exercise capacity, lung func-
tion or breathlessness. They reported that asthmatics
with high levels of anxiety experienced a cycle of fear
and avoidance, which may cause ‘signi¢cant levels of per-
sonal handicap with social and functional restriction
much greater than would be expected from the objec-
tivelymeasured physiologic level of impairment’. A treat-
ment aimed at reducing symptoms and improving
exercise capacity may not have a direct impact upon le-
vels on anxiety, since itmaybe thepatient’s perception oftheir health which needs to be addressed.Carr et al. (16)
have suggested that asthmatics with high levels of anxi-
ety might bene¢t from cognitive techniques designed to
address expectations, beliefs and exaggerated interpre-
tation ofbody sensations.This formof therapymight also
be appropriate for bronchiectasis patients experiencing
high levels of anxiety.
In conclusion, patients with bronchiectasis may ex-
perience elevated levels of anxiety, depression and re-
duced health status.There is no evidence of any distinct
sub-populations of patients with high levels of anxiety or
depression.Whilst the non-somatic components of de-
pression appear to be linked to dyspnoea and exercise
performance, the mechanisms underlying anxiety ap-
pear more compex. High levels of impaired mood were
related to poor subjectively perceived health, although
the nature of this link is not clear. Causality in the rela-
tionship between mood and impaired health and well-
being can only be established through trials of interven-
tions directed speci¢cally at one or other aspect of im-
pairedmood state.
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